Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Dev Biol ; 495: 76-91, 2023 03.
Article in English | MEDLINE | ID: mdl-36627077

ABSTRACT

We defined a temporally and transcriptionally divergent precursor cohort in the medial olfactory epithelium (OE) shortly after it differentiates as a distinct tissue at mid-gestation in the mouse. This temporally distinct population of Ascl1+ cells in the dorsomedial OE is segregated from Meis1+/Pax7+ progenitors in the lateral OE, and does not appear to be generated by Pax7+ lateral OE precursors. The medial Ascl1+ precursors do not yield a substantial number of early-generated ORNs. Instead, they first generate additional proliferative precursors as well as a distinct population of frontonasal mesenchymal cells associated with the migratory mass that surrounds the nascent olfactory nerve. Parallel to these in vivo distinctions, isolated medial versus lateral OE precursors in vitro retain distinct proliferative capacities and modes of division that reflect their in vivo identities. At later fetal stages, these early dorsomedial Ascl1+ precursors cells generate spatially restricted subsets of ORNs as well as other non-neuronal cell classes. Accordingly, the initial compliment of ORNs and other OE cell types is derived from at least two distinct early precursor populations: lateral Meis1/Pax7+ precursors that generate primarily early ORNs, and a temporally, spatially, and transcriptionally distinct subset of medial Ascl1+ precursors that initially generate additional OE progenitors and apparent migratory mass cells before yielding a subset of ORNs and likely supporting cell classes.


Subject(s)
Olfactory Mucosa , Olfactory Receptor Neurons , Mice , Animals , Epithelial Cells
2.
Hum Mol Genet ; 29(18): 3081-3093, 2020 11 04.
Article in English | MEDLINE | ID: mdl-32901287

ABSTRACT

We identified divergent modes of initial axon growth that prefigure disrupted differentiation of the trigeminal nerve (CN V), a cranial nerve essential for suckling, feeding and swallowing (S/F/S), a key innate behavior compromised in multiple genetic developmental disorders including DiGeorge/22q11.2 Deletion Syndrome (22q11.2 DS). We combined rapid in vivo labeling of single CN V axons in LgDel+/- mouse embryos, a genomically accurate 22q11.2DS model, and 3D imaging to identify and quantify phenotypes that could not be resolved using existing methods. We assessed these phenotypes in three 22q11.2-related genotypes to determine whether individual CN V motor and sensory axons wander, branch and sprout aberrantly in register with altered anterior-posterior hindbrain patterning and gross morphological disruption of CN V seen in LgDel+/-. In the additional 22q11.2-related genotypes: Tbx1+/-, Ranbp1-/-, Ranbp1+/- and LgDel+/-:Raldh2+/-; axon phenotypes are seen when hindbrain patterning and CN V gross morphology is altered, but not when it is normal or restored toward WT. This disordered growth of CN V sensory and motor axons, whose appropriate targeting is critical for optimal S/F/S, may be an early, critical determinant of imprecise innervation leading to inefficient oropharyngeal function associated with 22q11.2 deletion from birth onward.


Subject(s)
Aldehyde Oxidoreductases/genetics , DiGeorge Syndrome/genetics , Nuclear Proteins/genetics , T-Box Domain Proteins/genetics , Animals , Axons/metabolism , Axons/pathology , Chromosome Deletion , DiGeorge Syndrome/physiopathology , Disease Models, Animal , Humans , Mice , Mice, Knockout , Motor Activity/genetics , Phenotype , Rhombencephalon/growth & development , Rhombencephalon/physiopathology , Trigeminal Nerve/pathology
3.
Birth Defects Res ; 112(16): 1194-1208, 2020 10.
Article in English | MEDLINE | ID: mdl-32431076

ABSTRACT

BACKGROUND: Vitamin A regulates patterning of the pharyngeal arches, cranial nerves, and hindbrain that are essential for feeding and swallowing. In the LgDel mouse model of 22q11.2 deletion syndrome (22q11DS), morphogenesis of multiple structures involved in feeding and swallowing are dysmorphic. We asked whether changes in maternal dietary Vitamin A intake can modify cranial nerve, hindbrain and pharyngeal arch artery development in the embryo as well as lung pathology that can be a sign of aspiration dysphagia in LgDel pups. METHODS: Three defined amounts of vitamin A (4, 10, and 16 IU/g) were provided in the maternal diet. Cranial nerve, hindbrain and pharyngeal arch artery development was evaluated in embryos and inflammation in the lungs of pups to determine the impact of altering maternal diet on these phenotypes. RESULTS: Reduced maternal vitamin A intake improved whereas increased intake exacerbated lung inflammation in LgDel pups. These changes were accompanied by increased incidence and/or severity of pharyngeal arch artery and cranial nerve V (CN V) abnormalities in LgDel embryos as well as altered expression of Cyp26b1 in the hindbrain. CONCLUSIONS: Our studies demonstrate that variations in maternal vitamin A intake can influence the incidence and severity of phenotypes in a mouse model 22q11.2 deletion syndrome.


Subject(s)
DiGeorge Syndrome , Animals , Deglutition , Disease Models, Animal , Mice , Phenotype , Vitamin A
5.
Hum Mol Genet ; 29(6): 1002-1017, 2020 04 15.
Article in English | MEDLINE | ID: mdl-32047912

ABSTRACT

LgDel mice, which model the heterozygous deletion of genes at human chromosome 22q11.2 associated with DiGeorge/22q11.2 deletion syndrome (22q11DS), have cranial nerve and craniofacial dysfunction as well as disrupted suckling, feeding and swallowing, similar to key 22q11DS phenotypes. Divergent trigeminal nerve (CN V) differentiation and altered trigeminal ganglion (CNgV) cellular composition prefigure these disruptions in LgDel embryos. We therefore asked whether a distinct transcriptional state in a specific population of early differentiating LgDel cranial sensory neurons, those in CNgV, a major source of innervation for appropriate oropharyngeal function, underlies this departure from typical development. LgDel versus wild-type (WT) CNgV transcriptomes differ significantly at E10.5 just after the ganglion has coalesced. Some changes parallel altered proportions of cranial placode versus cranial neural crest-derived CNgV cells. Others are consistent with a shift in anterior-posterior patterning associated with divergent LgDel cranial nerve differentiation. The most robust quantitative distinction, however, is statistically verifiable increased variability of expression levels for most of the over 17 000 genes expressed in common in LgDel versus WT CNgV. Thus, quantitative expression changes of functionally relevant genes and increased stochastic variation across the entire CNgV transcriptome at the onset of CN V differentiation prefigure subsequent disruption of cranial nerve differentiation and oropharyngeal function in LgDel mice.


Subject(s)
DiGeorge Syndrome/pathology , Disease Models, Animal , Embryo, Mammalian/pathology , Gene Expression Regulation , Sensory Receptor Cells/pathology , Transcriptome , Trigeminal Nerve/pathology , Animals , DiGeorge Syndrome/genetics , Embryo, Mammalian/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Sensory Receptor Cells/metabolism , Trigeminal Nerve/metabolism
6.
Annu Rev Neurosci ; 43: 315-336, 2020 07 08.
Article in English | MEDLINE | ID: mdl-32101484

ABSTRACT

All mammals must suckle and swallow at birth, and subsequently chew and swallow solid foods, for optimal growth and health. These initially innate behaviors depend critically upon coordinated development of the mouth, tongue, pharynx, and larynx as well as the cranial nerves that control these structures. Disrupted suckling, feeding, and swallowing from birth onward-perinatal dysphagia-is often associated with several neurodevelopmental disorders that subsequently alter complex behaviors. Apparently, a broad range of neurodevelopmental pathologic mechanisms also target oropharyngeal and cranial nerve differentiation. These aberrant mechanisms, including altered patterning, progenitor specification, and neurite growth, prefigure dysphagia and may then compromise circuits for additional behavioral capacities. Thus, perinatal dysphagia may be an early indicator of disrupted genetic and developmental programs that compromise neural circuits and yield a broad range of behavioral deficits in neurodevelopmental disorders.


Subject(s)
Animals, Suckling/physiology , Deglutition Disorders/pathology , Nerve Net/physiology , Pharynx/pathology , Animals , Behavior/physiology , Deglutition/physiology , Deglutition Disorders/physiopathology , Humans , Pharynx/physiology
7.
Genesis ; 55(6)2017 06.
Article in English | MEDLINE | ID: mdl-28316121

ABSTRACT

Many molecular factors required for later stages of neuronal differentiation have been identified; however, much less is known about the early events that regulate the initial establishment of the neuroectoderm. We have used an in vitro embryonic stem cell (ESC) differentiation model to investigate early events of neuronal differentiation and to define the role of mouse Foxd4, an ortholog of a forkhead-family transcription factor central to Xenopus neural plate/neuroectodermal precursor development. We found that Foxd4 is a necessary regulator of the transition from pluripotent ESC to neuroectodermal stem cell, and its expression is necessary for neuronal differentiation. Mouse Foxd4 expression is not only limited to the neural plate but it is also expressed and apparently functions to regulate neurogenesis in the olfactory placode. These in vitro results suggest that mouse Foxd4 has a similar function to its Xenopus ortholog; this was confirmed by successfully substituting murine Foxd4 for its amphibian counterpart in overexpression experiments. Thus, Foxd4 appears to regulate the initial steps in establishing neuroectodermal precursors during initial development of the nervous system.


Subject(s)
Embryonic Stem Cells/metabolism , Forkhead Transcription Factors/genetics , Neural Stem Cells/metabolism , Neurogenesis , Animals , Cells, Cultured , Embryonic Stem Cells/cytology , Forkhead Transcription Factors/metabolism , Gene Expression Regulation, Developmental , Mice , Neural Plate/cytology , Neural Plate/metabolism , Neural Stem Cells/cytology , Xenopus
8.
Dev Biol ; 415(2): 228-241, 2016 07 15.
Article in English | MEDLINE | ID: mdl-26988119

ABSTRACT

We compared apparent origins, cellular diversity and regulation of initial axon growth for differentiating cranial sensory neurons. We assessed the molecular and cellular composition of the developing olfactory and otic placodes, and cranial sensory ganglia to evaluate contributions of ectodermal placode versus neural crest at each site. Special sensory neuron populations-the olfactory and otic placodes, as well as those in vestibulo-acoustic ganglion- are entirely populated with cells expressing cranial placode-associated, rather than neural crest-associated markers. The remaining cranial sensory ganglia are a mosaic of cells that express placode-associated as well as neural crest-associated markers. We found two distinct populations of neural crest in the cranial ganglia: the first, as expected, is labeled by Wnt1:Cre mediated recombination. The second is not labeled by Wnt1:Cre recombination, and expresses both Sox10 and FoxD3. These populations-Wnt1:Cre recombined, and Sox10/Foxd3-expressing- are proliferatively distinct from one another. Together, the two neural crest-associated populations are substantially more proliferative than their placode-associated counterparts. Nevertheless, the apparently placode- and neural crest-associated populations are similarly sensitive to altered signaling that compromises cranial morphogenesis and differentiation. Acute disruption of either Fibroblast growth factor (Fgf) or Retinoic acid (RA) signaling alters axon growth and cell death, but does not preferentially target any of the three distinct populations. Apparently, mosaic derivation and diversity of precursors and early differentiating neurons, modulated uniformly by local signals, supports early cranial sensory neuron differentiation and growth.


Subject(s)
Cranial Nerves/cytology , Sensory Receptor Cells/cytology , Animals , Apoptosis , Axons/physiology , Cell Differentiation , Cell Lineage , Cranial Nerves/embryology , Ectoderm/cytology , Fibroblast Growth Factors/physiology , Ganglia, Sensory/cytology , Gene Expression Regulation, Developmental/physiology , Luminescent Proteins/analysis , Luminescent Proteins/genetics , Mice , Mice, Inbred C57BL , Neural Crest/cytology , Neurogenesis , Transcription Factors/genetics , Tretinoin/physiology , Wnt1 Protein/physiology
9.
Gene Expr Patterns ; 20(1): 71-9, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26712358

ABSTRACT

Comparative genomic analysis of the nuclear receptor family suggests that the testicular receptor 2, Nr2c1, undergoes positive selection in the human-chimpanzee clade based upon a significant increase in nonsynonymous compared to synonymous substitutions. Previous in situ analyses of Nr2c1 lacked the temporal range and spatial resolution necessary to characterize cellular expression of this gene from early to mid gestation, when many nuclear receptors are key regulators of tissue specific stem or progenitor cells. Thus, we asked whether Nr2c1 protein is associated with stem cell populations in the mid-gestation mouse embryo. Nr2c1 is robustly expressed in the developing olfactory epithelium. Its expression in the olfactory epithelium shifts from multiple progenitor classes at early stages to primarily transit amplifying cells later in olfactory epithelium development. In the early developing central nervous system, Nr2c1 is limited to the anterior telencephalon/olfactory bulb anlagen, coincident with Nestin-positive neuroepithelial stem cells. Nr2c1 is also seen in additional cranial sensory specializations including cells surrounding the mystacial vibrissae, the retinal pigment epithelium and Scarpa's ganglion. Nr2c1 was also detected in a subset of mesenchymal cells in developing teeth and cranial bones. The timing and distribution of embryonic expression suggests that Nr2c1 is primarily associated with the early genesis of mammalian cranial sensory neurons and craniofacial skeletal structures. Thus, Nr2c1 may be a candidate for mediating parallel adaptive changes in cranial neural sensory specializations such as the olfactory epithelium, retina and mystacial vibrissae and in non-neural craniofacial features including teeth.


Subject(s)
Nuclear Receptor Subfamily 2, Group C, Member 1/biosynthesis , Olfactory Mucosa/embryology , Skull/embryology , Stem Cells/metabolism , Animals , Brain/embryology , Brain/metabolism , Facial Bones/embryology , Facial Bones/metabolism , Ganglia, Sensory/embryology , Ganglia, Sensory/metabolism , Gene Expression Profiling , Mice , Neural Stem Cells/metabolism , Olfactory Bulb/metabolism , Olfactory Mucosa/cytology , Olfactory Mucosa/metabolism , Skull/cytology , Skull/metabolism , Telencephalon/metabolism , Tooth/embryology , Tooth/metabolism
10.
Dev Cell ; 35(6): 789-802, 2015 Dec 21.
Article in English | MEDLINE | ID: mdl-26702835

ABSTRACT

After neural tube closure, amniotic fluid (AF) captured inside the neural tube forms the nascent cerebrospinal fluid (CSF). Neuroepithelial stem cells contact CSF-filled ventricles, proliferate, and differentiate to form the mammalian brain, while neurogenic placodes, which generate cranial sensory neurons, remain in contact with the AF. Using in vivo ultrasound imaging, we quantified the expansion of the embryonic ventricular-CSF space from its inception. We developed tools to obtain pure AF and nascent CSF, before and after neural tube closure, and to define how the AF and CSF proteomes diverge during mouse development. Using embryonic neural explants, we demonstrate that age-matched fluids promote Sox2-positive neurogenic identity in developing forebrain and olfactory epithelia. Nascent CSF also stimulates SOX2-positive self-renewal of forebrain progenitor cells, some of which is attributable to LIFR signaling. Our Resource should facilitate the investigation of fluid-tissue interactions during this highly vulnerable stage of early brain development.


Subject(s)
Amniotic Fluid/metabolism , Cell Differentiation/physiology , Cerebrospinal Fluid/metabolism , Neural Tube/metabolism , Neurons/cytology , Proteome/metabolism , Animals , Cells, Cultured , Female , Mice , Neuroepithelial Cells/metabolism , Pregnancy , Signal Transduction/physiology , Stem Cells/cytology
11.
Prog Neurobiol ; 130: 1-28, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25866365

ABSTRACT

Understanding the developmental etiology of autistic spectrum disorders, attention deficit/hyperactivity disorder and schizophrenia remains a major challenge for establishing new diagnostic and therapeutic approaches to these common, difficult-to-treat diseases that compromise neural circuits in the cerebral cortex. One aspect of this challenge is the breadth and overlap of ASD, ADHD, and SCZ deficits; another is the complexity of mutations associated with each, and a third is the difficulty of analyzing disrupted development in at-risk or affected human fetuses. The identification of distinct genetic syndromes that include behavioral deficits similar to those in ASD, ADHC and SCZ provides a critical starting point for meeting this challenge. We summarize clinical and behavioral impairments in children and adults with one such genetic syndrome, the 22q11.2 Deletion Syndrome, routinely called 22q11DS, caused by micro-deletions of between 1.5 and 3.0 MB on human chromosome 22. Among many syndromic features, including cardiovascular and craniofacial anomalies, 22q11DS patients have a high incidence of brain structural, functional, and behavioral deficits that reflect cerebral cortical dysfunction and fall within the spectrum that defines ASD, ADHD, and SCZ. We show that developmental pathogenesis underlying this apparent genetic "model" syndrome in patients can be defined and analyzed mechanistically using genomically accurate mouse models of the deletion that causes 22q11DS. We conclude that "modeling a model", in this case 22q11DS as a model for idiopathic ASD, ADHD and SCZ, as well as other behavioral disorders like anxiety frequently seen in 22q11DS patients, in genetically engineered mice provides a foundation for understanding the causes and improving diagnosis and therapy for these disorders of cortical circuit development.


Subject(s)
Chromosomes, Human, Pair 22/genetics , DiGeorge Syndrome/genetics , Genetic Predisposition to Disease/genetics , Mice , Animals , Cerebral Cortex/pathology , Disease Models, Animal , Humans , Schizophrenia/genetics
12.
Dev Biol ; 392(2): 368-80, 2014 Aug 15.
Article in English | MEDLINE | ID: mdl-24855001

ABSTRACT

The placenta plays a critical role in the growth and survival of the fetus. Here we demonstrate that the Homologous to the E6-AP Carboxyl Terminus (HECT) domain E3 ubiquitin ligase, Hectd1, is essential for development of the mouse placenta. Hectd1 is widely expressed during placentation with enrichment in trophoblast giant cells (TGCs) and other trophoblast-derived cell subtypes in the junctional and labyrinth zones of the placenta. Disruption of Hectd1 results in mid-gestation lethality and intrauterine growth restriction (IUGR). Variable defects in the gross structure of the mutant placenta are found including alterations in diameter, thickness and lamination. The number and nuclear size of TGCs is reduced. Examination of subtype specific markers reveals altered TGC development with decreased expression of Placental lactogen-1 and -2 (Pl1 and Pl2) and increased expression of Proliferin (Plf). Reduced numbers of spongiotrophoblasts and glycogen trophoblasts were also found at the junctional zone of the Hectd1 mutant placenta. Finally, there was an increase in immature uterine natural killer (uNK) cells in the maternal decidua of the Hectd1 mutant placenta. Proliferation and apoptosis are differentially altered in the layers of the placenta with an increase in both apoptosis and proliferation in the maternal decidua, a decrease in proliferation and increase in apoptosis in the labyrinth layer and both unchanged in the junctional zone. Together these data demonstrate that Hectd1 is required for development of multiple cell types within the junctional zone of the placenta.


Subject(s)
Cell Differentiation/physiology , Placentation , Trophoblasts/cytology , Ubiquitin-Protein Ligases/metabolism , Animals , Blotting, Western , Female , Giant Cells/cytology , Giant Cells/metabolism , Glycoproteins/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Killer Cells, Natural/metabolism , Mice , Placenta/cytology , Placenta/metabolism , Placental Lactogen/metabolism , Pregnancy , Prolactin , Trophoblasts/metabolism
13.
Dis Model Mech ; 7(2): 245-57, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24357327

ABSTRACT

We assessed feeding-related developmental anomalies in the LgDel mouse model of chromosome 22q11 deletion syndrome (22q11DS), a common developmental disorder that frequently includes perinatal dysphagia--debilitating feeding, swallowing and nutrition difficulties from birth onward--within its phenotypic spectrum. LgDel pups gain significantly less weight during the first postnatal weeks, and have several signs of respiratory infections due to food aspiration. Most 22q11 genes are expressed in anlagen of craniofacial and brainstem regions critical for feeding and swallowing, and diminished expression in LgDel embryos apparently compromises development of these regions. Palate and jaw anomalies indicate divergent oro-facial morphogenesis. Altered expression and patterning of hindbrain transcriptional regulators, especially those related to retinoic acid (RA) signaling, prefigures these disruptions. Subsequently, gene expression, axon growth and sensory ganglion formation in the trigeminal (V), glossopharyngeal (IX) or vagus (X) cranial nerves (CNs) that innervate targets essential for feeding, swallowing and digestion are disrupted. Posterior CN IX and X ganglia anomalies primarily reflect diminished dosage of the 22q11DS candidate gene Tbx1. Genetic modification of RA signaling in LgDel embryos rescues the anterior CN V phenotype and returns expression levels or pattern of RA-sensitive genes to those in wild-type embryos. Thus, diminished 22q11 gene dosage, including but not limited to Tbx1, disrupts oro-facial and CN development by modifying RA-modulated anterior-posterior hindbrain differentiation. These disruptions likely contribute to dysphagia in infants and young children with 22q11DS.


Subject(s)
Chromosome Deletion , Cranial Nerves/embryology , Cranial Nerves/pathology , Deglutition Disorders/embryology , Deglutition Disorders/pathology , Animals , Animals, Newborn , Body Patterning/genetics , Craniofacial Abnormalities/pathology , Craniofacial Abnormalities/physiopathology , Deglutition , Deglutition Disorders/genetics , Deglutition Disorders/physiopathology , DiGeorge Syndrome , Disease Models, Animal , Embryo, Mammalian/abnormalities , Embryo, Mammalian/pathology , Feeding Behavior , Female , Gene Dosage , Gene Expression Regulation, Developmental , Male , Mice , Phenotype , Rhombencephalon/abnormalities , Rhombencephalon/embryology , Rhombencephalon/pathology , Signal Transduction , T-Box Domain Proteins/metabolism , Tretinoin/metabolism
14.
J Vis Exp ; (73): e50333, 2013 Mar 11.
Article in English | MEDLINE | ID: mdl-23524481

ABSTRACT

The CSF is a complex fluid with a dynamically varying proteome throughout development and in adulthood. During embryonic development, the nascent CSF differentiates from the amniotic fluid upon closure of the anterior neural tube. CSF volume then increases over subsequent days as the neuroepithelial progenitor cells lining the ventricles and the choroid plexus generate CSF. The embryonic CSF contacts the apical, ventricular surface of the neural stem cells of the developing brain and spinal cord. CSF provides crucial fluid pressure for the expansion of the developing brain and distributes important growth promoting factors to neural progenitor cells in a temporally-specific manner. To investigate the function of the CSF, it is important to isolate pure samples of embryonic CSF without contamination from blood or the developing telencephalic tissue. Here, we describe a technique to isolate relatively pure samples of ventricular embryonic CSF that can be used for a wide range of experimental assays including mass spectrometry, protein electrophoresis, and cell and primary explant culture. We demonstrate how to dissect and culture cortical explants on porous polycarbonate membranes in order to grow developing cortical tissue with reduced volumes of media or CSF. With this method, experiments can be performed using CSF from varying ages or conditions to investigate the biological activity of the CSF proteome on target cells.


Subject(s)
Cerebral Cortex/chemistry , Cerebrospinal Fluid Proteins/analysis , Cerebrospinal Fluid/chemistry , Animals , Cerebral Cortex/surgery , Dissection/methods , Embryo, Mammalian , Mice , Proteome/analysis , Rats
15.
Neuron ; 69(5): 893-905, 2011 Mar 10.
Article in English | MEDLINE | ID: mdl-21382550

ABSTRACT

Cortical development depends on the active integration of cell-autonomous and extrinsic cues, but the coordination of these processes is poorly understood. Here, we show that the apical complex protein Pals1 and Pten have opposing roles in localizing the Igf1R to the apical, ventricular domain of cerebral cortical progenitor cells. We found that the cerebrospinal fluid (CSF), which contacts this apical domain, has an age-dependent effect on proliferation, much of which is attributable to Igf2, but that CSF contains other signaling activities as well. CSF samples from patients with glioblastoma multiforme show elevated Igf2 and stimulate stem cell proliferation in an Igf2-dependent manner. Together, our findings demonstrate that the apical complex couples intrinsic and extrinsic signaling, enabling progenitors to sense and respond appropriately to diffusible CSF-borne signals distributed widely throughout the brain. The temporal control of CSF composition may have critical relevance to normal development and neuropathological conditions.


Subject(s)
Cerebral Cortex/physiology , Cerebrospinal Fluid/physiology , Neural Stem Cells/physiology , Analysis of Variance , Animals , Brain Neoplasms/cerebrospinal fluid , Cell Proliferation , Cerebral Cortex/cytology , Glioblastoma/cerebrospinal fluid , Humans , Insulin-Like Growth Factor II/metabolism , Membrane Proteins/metabolism , Mice , Neural Stem Cells/cytology , Neurons/metabolism , Nucleoside-Phosphate Kinase/metabolism , PTEN Phosphohydrolase/metabolism , Receptor, IGF Type 1/metabolism , Statistics, Nonparametric
16.
Neuron ; 66(1): 69-84, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20399730

ABSTRACT

Cortical development depends upon tightly controlled cell fate and cell survival decisions that generate a functional neuronal population, but the coordination of these two processes is poorly understood. Here we show that conditional removal of a key apical complex protein, Pals1, causes premature withdrawal from the cell cycle, inducing excessive generation of early-born postmitotic neurons followed by surprisingly massive and rapid cell death, leading to the abrogation of virtually the entire cortical structure. Pals1 loss shows exquisite dosage sensitivity, so that heterozygote mutants show an intermediate phenotype on cell fate and cell death. Loss of Pals1 blocks essential cell survival signals, including the mammalian target of rapamycin (mTOR) pathway, while mTORC1 activation partially rescues Pals1 deficiency. These data highlight unexpected roles of the apical complex protein Pals1 in cell survival through interactions with mTOR signaling.


Subject(s)
Cell Differentiation/physiology , Cerebral Cortex/metabolism , Neurogenesis/physiology , Neurons/cytology , Signal Transduction/physiology , Animals , Cell Differentiation/genetics , Cell Survival/genetics , Cerebral Cortex/cytology , Cerebral Cortex/growth & development , Gene Expression Regulation, Developmental/physiology , Gene Targeting , Intracellular Signaling Peptides and Proteins/metabolism , Membrane Proteins , Mice , Mice, Transgenic , Neurogenesis/genetics , Neurons/metabolism , Nucleoside-Phosphate Kinase , Organogenesis/genetics , Organogenesis/physiology , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/genetics , TOR Serine-Threonine Kinases
17.
Mol Interv ; 3(1): 27-39, 2003 Feb.
Article in English | MEDLINE | ID: mdl-14993436

ABSTRACT

Despite great progress in basic schizophrenia research, the conclusive identification of specific etiological factors or pathogenic processes in the illness has remained elusive. The convergence of modern neuroscientific studies in molecular genetics, molecular neuropathology, neurophysiology, in vivo brain imaging, and psychopharmacology, however, indicates that we may be coming much closer to understanding the molecular basis of schizophrenia. Schizophrenia may be a neurodevelopmental and progressive disorder with multiple biochemical abnormalities involving the dopaminergic, serotonin, glutamate, and gamma -aminobutyric acidergic systems. In the near future, biological markers for the illness may come from the combination of diverse assessment techniques. An understanding of the pathophysiology of schizophrenia will be essential to the discovery of preventive measures and therapeutic intervention. Rapidly advancing research into schizophrenia includes diverse etiological hypotheses, and offers directions for future research and treatments.


Subject(s)
Brain/physiopathology , Genetic Variation , Schizophrenia/genetics , Schizophrenia/physiopathology , Antipsychotic Agents/pharmacology , Antipsychotic Agents/therapeutic use , Biomarkers , Brain/pathology , Chromosome Mapping , Disease Susceptibility , Genetic Linkage , Genetic Predisposition to Disease , Humans , Oligonucleotide Array Sequence Analysis/methods , Risk Factors , Schizophrenia/metabolism , Schizophrenia/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...